Minervax ApS
http://minervax.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Minervax ApS
Deal Watch: Lilly, Innovent Build On Long Alliance To Partner On Three Cancer Drugs
Bookmark
-
News
Under deal amendment, Innovent gets Asia rights to Cyramza, Retevmo and pirtobrutinib.
Finance Watch: Three Neurology-Focused Firms Raise VC Mega-Rounds
Bookmark
-
News
Private Company Watch: Neuron23, Neurogene and Locanabio each raised $100m or more, highlighting increased investor interest in novel approaches to neurological diseases. Also, CRO dMed raised $100m and MinervaX brought in $57m for its vaccine to protect newborns.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
Advertisement
Advertisement